Featured

The turnaround expert shares his take on covid-19's impact on PE, asserting that he's seeing MAC clauses implemented for the first time in his 20-year career.

Imprivata, which helps healthcare providers protect patient information, was anticipated to command upwards of $2bn in a potential sale.

Areas of the healthcare industry will likely be triggered into action, spurring innovation, as bottlenecks in the system become increasingly clear amid covid-19, Adams told PE Hub.

Chris Gaffney, managing partner at Great Hill Partners, recently talked to PE Hub about priorities for the Boston-based firm amidst the pandemic.

Coronavirus forces gym, yoga studios and other fitness centers to shutter shops, halting cash flow.

The company’s business model is likely to remain resilient to a downturn triggered by the covid-19 outbreak, one of the sources said.

Barclays and Moelis have been engaged for sell-side financial advice, however the timeline of the process is unclear amid market uncertainty.

As the JPM and Rothschild process for the French nuclear medicine company is put on hold, attention shifts to Webster Equity-backed PharmaLogic, sources told PE Hub.

TSG Consumer makes a big splash in vet care amid other activity in the lower middle market, with L1 Health's Destination Pet buying VitalPet out of bankruptcy following Cortec's recent acquisition of Lap of Love.

PE firm acquires over $600m in revenue paper company for below average market rate.